RCAT Red Cat Holdings, Inc. Insider Trading

Director Paul Ii Funk sold entire 165.0K share stake (100.0% of holdings) for $1.9M at $11.50 on 2026-06-11.

Director Paul Ii Funk liquidated his complete position in Red Cat Holdings, divesting 165,028 shares worth $1,897,822.00. This represents a complete exit from equity ownership at a price ($11.50) that is 36.3% below the 52-week high of $18.78, occurring in a stock that has declined 29.5% over the prior 90 days. The transaction is notable given the company's ongoing unprofitability (net income of $-26,553,000.00 in the latest fiscal year) despite strong top-line growth of 876.0% year-over-year, suggesting the company is rapidly scaling revenue but burning cash. A director's full exit from ownership warrants investor attention to management's perspective on near-term prospects and capital allocation priorities.

Director Liuzza sells 200,309 shares ($1.5M) across two transactions; holdings reduced 34.1% to 387,445 shares

Director Nicholas Reyland Liuzza JR executed two separate sales totaling 200,309 shares for $1,529,769.37, reducing his holdings by 34.1% from 587,754 shares to 387,445 shares. The sales occurred at $6.70 on 2025-05-21 and $8.58 on 2025-06-10, with a blended average price of $7.64, compared to the current price of $6.89 (down 51.4% from the 52-week high of $14.19). The company generated $1,629,662.00 in revenue last quarter but reported a net loss of $-23,123,351.00, indicating sustained unprofitability despite 80.0% annual revenue growth. This substantial reduction in director equity stake occurs against the backdrop of a stock down 21.7% over the past 30 days and a company that remains unprofitable, factors investors should evaluate in context of the director's confidence in near-term prospects.

Director Freedman sells 150,000 RCAT shares at $7.37 (now $6.79, -52.2% from 52w high)

Director Joseph David Freedman sold 150,000 shares (47.6% reduction in his pre-transaction holdings) at $7.37 on 2025-06-30, while the stock has since declined to $6.79 and sits 52.2% below its 52-week high of $14.19. Fundamentally, Red Cat Holdings reported net income of -$23,123,351 (negative) over its most recent full fiscal year despite revenue of $1,629,662 in the latest quarter and 80% annual revenue growth, signaling substantial unprofitability alongside top-line expansion. Freedman's cross-ticker track record shows 15 prior open-market buys with a 0.00% 90-day win rate and average 90-day returns of -73.7%, indicating a pattern of entries that systematically underperformed in the medium term, a context that frames this discretionary sale against a history of poorly-timed entries elsewhere.

Director Liuzza sells 80,000 shares of RCAT at $13.46 for $1.1M, reducing stake to 381.1K shares.

Director Liuzza Nicholas Reyland JR sold 80,000 shares (-17.4% vs pre-transaction holdings) on 2024-12-30 at $13.46 per share, totaling $1,076,800.00. This sale follows a series of three other sales at the same ticker within the prior seven days (2024-12-18, 2024-12-23, and 2024-12-26), establishing a pattern of sustained selling. The company generated revenue of $1,534,727.00 in the latest quarter but posted a net loss of $-13,334,618.00 and remained unprofitable over its most recent full fiscal year, despite 80.0% annual revenue growth. The sale occurred near the 52-week high ($14.09 current price, +0.0% from the high), yet the stock advanced 19.7% over the prior 30 days and 379.2% over the prior 90 days, providing favorable exit conditions. Investors should note both the concentrated selling pattern and the underlying unprofitability alongside the recent equity appreciation.

Red Cat CTO Matus George Michael sold 381,584 shares for $5,287,518.51 across 3 transactions, reducing stake by 55.6%

Matus George Michael, Red Cat's CTO, executed 3 separate sales totaling 381,584 shares for $5,287,518.51 between December 18–26, 2024, at prices ranging from $12.10 to $14.67 (blended average $13.86), reducing his holdings from 685,990 to 304,406 shares (55.6% reduction). This follows a dramatic 378.9% gain over 90 days and a 32.2% surge over 30 days, coinciding with the stock recovering from a 52-week low of $0.58 toward $13.41. The company remains unprofitable (net income -$13.3M on latest-quarter revenue of $1.5M), though full-year revenue grew 80.0%. His rapid series of liquidation sales near the 52-week high, combined with the company's ongoing cash-burn profile and absence of profitability, warrants investor scrutiny regarding the CTO's confidence in near-term prospects.

Director Liuzza sold 220,000 shares (32.3% of holdings) at $11.08 avg, stock now $13.41

Director Nicholas Reyland JR Liuzza executed two separate sales totaling 220,000 shares for $2,438,400.00, reducing his holdings from 681,072 shares to 461,072 shares. The sales occurred at $10.80 (200,000 shares on 2024-12-23) and $13.92 (20,000 shares on 2024-12-26), yielding a blended average price of $11.08. The stock has since appreciated to $13.41, suggesting these sales occurred before a near-term price advance—a pattern inconsistent with well-timed sell exits. The company remains unprofitable on a full-year basis despite 80.0% annual revenue growth and a market cap of $1.1B, creating structural tension between expansion momentum and bottom-line performance. The disposal of one-third of his position warrants attention, though the modest equity base (461,072 shares remaining) and recent price momentum complicate inference about directional conviction.

Red Cat CRO sold 113.8K shares for $1.2M on 2024-12-20; stock at 52-week high +60.4% in 30 days

Geoffrey Wayne Hitchcock, Chief Revenue Officer at Red Cat Holdings, executed 2 separate sales on 2024-12-20, disposing of 113,823 shares for a blended average price of $10.44 against a current price of $13.41. This represents a 16.9% reduction in his post-transaction holdings of 558,325 shares. The stock has appreciated materially: 30-day change of +60.4% and 90-day change of +423.8%, and currently trades at its 52-week high. The company remains unprofitable with a net income of $-13,334,618.00 over its most recent full fiscal year, though annual revenue growth reached +80.0%. The timing—execution near the 52-week peak and following substantial recent momentum—combined with the reduction in his equity stake, warrants review of management's capital allocation priorities and conviction regarding the company's valuation trajectory.

CEO Thompson sells 500,000 shares (3 sales totaling $5.7M) near 52-week high as stock surges 423.8% in 90 days

Thompson Jeffrey M, Chairman and CEO, executed three separate sales totaling 500,000 shares for $5,737,057.24 between December 23-26, 2024, at an average price of $11.47 per share. The sales occur as RCAT stock has climbed to its 52-week high of $13.41 (+423.8% over 90 days and +60.4% over 30 days), representing a sharp acceleration in valuation despite fundamental challenges: the company reported revenue of $1,534,727.00 in its latest quarter and negative net income of $-13,334,618.00, with the company unprofitable over its most recent full fiscal year. Thompson's post-transaction holdings of 13,014,449 shares remain substantial (3.7% reduction from pre-transaction 13,514,449 shares), preserving significant founder alignment, yet the timing during a steep rally against a backdrop of ongoing losses presents a notable divergence between insider action and the equity narrative driving the stock's recent momentum.

CTO Matus George Michael sold 287,113 shares of RCAT at $9.94 on 2024-12-20 (total $2,853,903.22), reducing holdings 29.5% post-transaction.

Matus George Michael, serving as CTO, executed a substantial open-market sale of 287,113 shares worth $2,853,903.22 near the stock's recent highs, reducing his stake from 973,103 shares to 685,990 shares. The sale occurred when RCAT was trading at $9.94, within 6.3% of its 52-week high of $11.77, and followed a 325.9% rally over 90 days and +23.0% gain over the prior 30 days. The company is unprofitable, with net income of $-13,334,618.00 against quarterly revenue of $1,534,727.00, despite reporting 80.0% annual revenue growth. This sizable reduction of a C-level executive's shareholding during a period of elevated valuation and after substantial price appreciation warrants investor attention, particularly given the company's ongoing losses despite revenue expansion.

Director Liuzza Nicholas Reyland JR sold 328,928 shares (328.9K) at blended $8.29 for $2.7M, reducing stake 32.6%

Director Liuzza Nicholas Reyland JR executed 2 separate sales totaling 328,928 shares for $2,728,176.26, reducing his holdings from 1,010,000 shares to 681,072 shares (a -32.6% reduction). The blended average sale price was $8.29, which stands notably below the current price of $10.75, suggesting the stock has appreciated 29.7% since the transaction date. Against this backdrop, the company reported a latest quarterly revenue of $1,534,727.00 ($1.5M) and a full-year net income of $-13,334,618.00 ($-13.3M), indicating material unprofitability. This large discretionary reduction of a director's position while the stock trades 68.8% higher over the prior 30 days and the company remains unprofitable warrants monitoring of both the director's confidence level and the stock's current valuation relative to fundamentals.